BrightSpring Health Services, I
BTSG · Healthcare
$59.16
Loading chart…
News
Latest headlines for this stock
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services (BTSG) reported acute infusion volume growth exceeding 20% year-over-year in Q2, roughly 7-8x the overall infusion market growth rate. The company plans to expand into 12-15 additional states over five years to capitalize on a fragmented $20 billion addressable market. Management is investing in infrastructure, AI-enabled intake, and analytics to support expansion, with the stock up 64% year-to-date and rated as a Zacks Rank #1 Strong Buy.
NVIDIA & 2 Profitable Stocks to Buy in September for Big Upside
As September historically brings market volatility, investors should focus on highly profitable companies with strong net income ratios and earnings growth. Three standout stocks meeting rigorous profitability criteria are NVIDIA (63.7% net margin, 93.3% earnings growth), BrightSpring Health Services (2.6% net margin, 82% earnings growth), and Comfort Systems USA (12.8% net margin, 60.7% earnings growth).
Here's Why Investors Should Stay Neutral on TDOC Stock for Now
Teladoc Health (TDOC) is positioned for growth through chronic care expansion, international presence, and its upcoming Teladoc One platform, with the stock trading at a valuation discount. However, the company faces headwinds from declining BetterHelp revenues, intense virtual care competition, and persistent unprofitability with a $16.5 billion accumulated deficit.